Vesizen 5mg Tablet contains Solifenacin succinate, an antimuscarinic agent that selectively inhibits bladder muscle contractions. This medication effectively treats overactive bladder symptoms including urinary urgency, frequency, and incontinence.
Uses
Vesizen 5mg Tablet treats overactive bladder syndrome characterized by sudden urges to urinate, frequent urination, and urinary incontinence. It helps patients regain bladder control, reduce bathroom visits, and prevent embarrassing leakage incidents.
Benefits
- Reduces urinary urgency episodes
- Decreases frequency of urination
- Minimizes incontinence episodes
- Increases bladder capacity
- Improves sleep quality by reducing nighttime urination
- Enhances quality of life and social confidence
- Provides 24-hour symptom control
- Shows effectiveness within 1-2 weeks
- Well-tolerated by most patients
How It Works
Solifenacin selectively blocks M3 muscarinic receptors in the bladder detrusor muscle, inhibiting involuntary contractions. This relaxes the bladder muscle, increases bladder capacity, and reduces the urge to urinate. The medication’s selectivity helps minimize side effects compared to non-selective antimuscarinic agents.
Dosage
| Patient Group | Starting Dose | Maximum Dose |
|---|---|---|
| Adults | 5mg once daily | 10mg once daily |
| Elderly | 5mg once daily | 5mg once daily |
Take Vesizen with water, with or without food. Swallow tablet whole, do not crush or chew. Take at the same time each day.
Duration of Action
Vesizen begins working within 1 week, with optimal effects typically achieved within 2-4 weeks of consistent use. Each dose provides 24-hour relief from overactive bladder symptoms. The medication may require 12 weeks for maximum therapeutic benefit in some patients.
Side Effects
Common side effects include dry mouth, constipation, and blurred vision. Less frequent effects include dry eyes, headache, and digestive discomfort. Severe but rare side effects include urinary retention, severe allergic reactions, and confusion. Most side effects are mild to moderate and diminish over time.
Warning
Do not use Vesizen if you have urinary retention, severe gastrointestinal conditions, uncontrolled narrow-angle glaucoma, or myasthenia gravis. Discontinue and seek medical attention if experiencing severe abdominal pain, constipation lasting over 3 days, or difficulty urinating. This medication may cause drowsiness or blurred vision affecting driving ability.
Pregnancy and Breastfeeding
Not recommended during pregnancy unless clearly necessary and potential benefits outweigh risks. Limited data exists on pregnancy safety. Solifenacin passes into breast milk; avoid use while breastfeeding or discontinue breastfeeding during treatment after discussing with healthcare provider.
Interaction
- May increase effects of other anticholinergic medications
- Potential interaction with CYP3A4 inhibitors (ketoconazole, clarithromycin)
- May affect absorption of medications requiring specific gastric pH
- Possible increased side effects with cholinesterase inhibitors
- May interact with certain antipsychotic medications
Precaution
Use cautiously in patients with kidney or liver impairment, bladder outflow obstruction, gastrointestinal obstructive disorders, decreased gastrointestinal motility, hiatal hernia, or controlled narrow-angle glaucoma. Monitor elderly patients more closely for side effects. Stay hydrated while taking this medication.
Important Information
Vesizen relieves symptoms but does not cure overactive bladder. Benefits may take several weeks to become fully apparent. Continue taking as prescribed even after symptoms improve. Regular follow-up with healthcare provider is essential to monitor effectiveness and adjust dosage if needed. Implement lifestyle modifications like scheduled voiding and limiting evening fluid intake alongside medication for optimal results.
Reviews
There are no reviews yet.